Enzalutamide
Pfizer,Astellas
['prostate', 'congrat', 'brca']
congrats to . important presentation underscoring the differences between brca1/2, non-brca hrr must, and non-hrr mutant prostate ca. this is a different disease! #asco23 
Director, Experimental Program; Medical Director, Urologic Oncology DRG / Center for Uro-Oncology Research Excellence (CURE) Cedars-Sinai-Cancer